Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CHARTWELL MOLECULAR

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 27
  • 0 comments

FDA approve ESCITALOPRAM OXALATE

Comment Full text

SAPTALIS PHARMS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 43
  • 0 comments

FDA approve LITHIUM CITRATE

Comment Full text

MYLAN

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 44
  • 0 comments

FDA approve PRAMIPEXOLE DIHYDROCHLORIDE

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 36
  • 0 comments

FDA approve PONATINIB HYDROCHLORIDE

Comment Full text

LANNETT CO INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 42
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

DR REDDYS LABS SA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 39
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

DR REDDYS LABS SA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

SANDOZ

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 27
  • 0 comments

FDA approve GLATIRAMER ACETATE

Comment Full text

ABON PHARMS LLC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 43
  • 0 comments

FDA approve SUCRALFATE

Comment Full text

SUN PHARM

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text
  • Previous
  • 497
  • 498
  • 499
  • 500
  • 501
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393628)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239514)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin